BioWorld - Tuesday, February 10, 2026

BioWorld Science

July 28, 1998

View Archived Issues

Health Canada gives the go-ahead for clinical testing of TH-9402

Read More

Millennium, Wyeth-Ayerst identify another CNS gene target

Read More

Fuisz and Novopharm enter agreements for CEFORM CR technology

Read More

Cognition-enhancing and antidepressant agent available from BTG

Read More

Intercardia signs license to develop drug for IBD

Read More

Hybridon and Searle extend and expand antisense research collaboration

Read More

Novel gamma-aminobutyric acids related to gabapentin prepared at Warner-Lambert

Read More

Advanced Viral Research to initiate clinical trials with Reticulose in Mexico

Read More

Dainippon's new agents for urinary incontinence

Read More

New heterocyclic compounds inhibit cardiac chymase activity

Read More

Antiplatelet agents in the pipeline at Boehringer Ingelheim

Read More

Daiichi patents compounds for enhancing bacterial sensitivity to antimicrobial agents

Read More

Cypress Bioscience files PMA for Prosorba Column

Read More

AIT-082: a new neuroregenerative compound

Read More

Effects of RGH-2716 on neurotransmitter release and cerebral energy metabolism

Read More

Mechanism of action, anxiolytic and anticonvulsant activity of AWD-131-138

Read More

NDA filed for magainin antibiotic for infected diabetic foot ulcers

Read More

Biogen: Q2 1998 highlights

Read More

Multiyear drug delivery agreement signed by Bioglan and Novo Nordisk

Read More

Dura acquires U.S. marketing rights to Myambutol

Read More

Cel-Sci, U of Maryland receive state funding for TB test

Read More